{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T01:48:29Z","timestamp":1769392109707,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100018507","name":"Japan Medical Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartandlung.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart &amp; Lung"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.hrtlng.2008.01.002","type":"journal-article","created":{"date-parts":[[2008,9,18]],"date-time":"2008-09-18T12:00:56Z","timestamp":1221739256000},"page":"48-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Beta-1 selective adrenergic antagonist landiolol and esmolol can be safely used in patients with airway hyperreactivity"],"prefix":"10.1016","volume":"38","author":[{"given":"Michiaki","family":"Yamakage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohshi","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong-Wook","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Ichi","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyoshi","family":"Namiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrtlng.2008.01.002_bib1","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.283.10.1295","article-title":"Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR\/XL randomized intervention trial in congestive heart failure (MERIT-HF)","volume":"283","author":"Hjalmarson","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1592\/phco.20.6.495.35164","article-title":"HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction\u2014pharmacological approaches","volume":"20","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib3","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0735-1097(96)00392-0","article-title":"ACC\/AHA guidelines for the management of patients with acute myocardial infarction","volume":"28","author":"Ryan","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib4","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0140-6736(64)92617-0","article-title":"Effect of a beta-adrenergic blocking agent, propranolol, on asthmatics","volume":"13","author":"McMeill","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib5","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/bmj.282.6263.548","article-title":"Near-fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane","volume":"282","author":"Raine","year":"1981","journal-title":"Br J Med (Clin Res Ed)"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/thx.35.2.160","article-title":"Severe asthma after inadvertent ingestion of oxprenolol","volume":"35","author":"Williams","year":"1980","journal-title":"Thorax"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib7","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1136\/bmj.282.6272.1321-b","article-title":"Beta-blockade in asthma","volume":"282","author":"Harries","year":"1981","journal-title":"Br J Med (Clin Res Ed)"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib8","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM198411293112213","article-title":"Respiratory effects of timolol","volume":"311","author":"Fraunfelder","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib9","first-page":"97","article-title":"Timolol eyedrop-induced fatal bronchospasm in an asthmatic patient","volume":"32","author":"Odeh","year":"1991","journal-title":"J Fam Pract"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0272-5231(21)00680-8","article-title":"Drug-induced bronchospasm","volume":"11","author":"Meeker","year":"1990","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib11","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMcp010357","article-title":"Initial treatment of hypertension","volume":"348","author":"August","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib12","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/S0735-1097(01)01225-6","article-title":"Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma","volume":"37","author":"Chen","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib13","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1081\/JAS-120025582","article-title":"Cardioselective beta-blockers in patients with asthma and concomitant heart failure or history of myocardial infarction: when do benefits outweigh risks?","volume":"40","author":"Self","year":"2003","journal-title":"J Asthma"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib14","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/0003-4819-137-9-200211050-00035","article-title":"Cardiovascular beta-blockers in patients with reactive airway disease: a meta-analysis","volume":"137","author":"Salpeter","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1213\/00000539-198503000-00005","article-title":"Cardiovascular effects of esmolol in anesthetized humans","volume":"64","author":"Menkhaus","year":"1985","journal-title":"Anesth Analg"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/j.1552-4604.1986.tb02929.x","article-title":"Effects of esmolol on airway function in patients with asthma","volume":"26","author":"Sheppard","year":"1986","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib17","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1378\/chest.100.5.1215","article-title":"Esmolol and ventilatory function in cardiac patients with COPD","volume":"100","author":"Gold","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib18","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1248\/cpb.40.1462","article-title":"Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101","volume":"40","author":"Iguchi","year":"1992","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000028295","article-title":"Increased muscarinic receptor blockade by atropine in tracheal chains of ovalbumin-sensitized guinea pigs","volume":"58","author":"Boskabady","year":"1999","journal-title":"Pharmacology"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1164\/ajrccm.161.1.9809121","article-title":"Airway hyperresponsiveness to cigarette smoke in ovalbumin-sensitized guinea pigs","volume":"161","author":"Wu","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2222.2004.01833.x","article-title":"Early and late bronchoconstrictions, airway hyperreactivity, leucocyte influx and lung histamine and nitric oxide after inhaled antigen: effects of dexamethasone and rolipram","volume":"34","author":"Toward","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib22","first-page":"213","article-title":"Use of an analog on-line computer for the evaluation of pulmonary resistance and dynamic compliance in the anesthetized dog","volume":"194","author":"Giles","year":"1971","journal-title":"Arch Int Pharmacodyn"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/jama.1992.03490020053030","article-title":"Predictors of postoperative myocardial ischemia in patients undergoing noncardiac surgery","volume":"268","author":"Hollenberg","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1213\/01.ANE.0000154441.22654.11","article-title":"The short-acting beta1-adrenoceptor antagonists esmolol and landiolol suppress the bispectral index response to tracheal intubation during sevoflurane anesthesia","volume":"100","author":"Oda","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib25","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/00000542-200405000-00004","article-title":"Corticosteroids and inhaled salbutamol in patients with reversible airway obstruction markedly decrease the incidence of bronchospasms after tracheal intubation","volume":"100","author":"Silvanus","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib26","series-title":"Textbook of respiratory medicine","first-page":"443","article-title":"History and physical examination","author":"Murray","year":"1989"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0952-0600(89)90026-4","article-title":"Animal models of asthma","volume":"2","author":"Smith","year":"1989","journal-title":"Pulm Pharmacol"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0162-3109(00)00240-X","article-title":"Intratracheal administration of anaphylatoxin C5a potentiates antigen-induced pulmonary reactions through the prolonged production of cysteinyl-leukotrienes","volume":"49","author":"Kodani","year":"2000","journal-title":"Immunopharmacol"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib29","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.4049\/jimmunol.167.8.4651","article-title":"Contribution of anaphylatoxin C5a to late airway responses after repeated exposure of antigen to allergic rats","volume":"167","author":"Abe","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib30","first-page":"L263","article-title":"Hyperoxia-induced airway hyperresponsiveness and remodeling in immature rats","volume":"262","author":"Hershenson","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib31","first-page":"2913","article-title":"Pharmacological studies of ONO-1101 as a beta-blocking agent with high beta1-selectivity and ultra-short duration of action","volume":"31","author":"Shiroya","year":"1997","journal-title":"KISO TO EINSHO (written in Japanese)"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib32","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1248\/cpb.40.1462","article-title":"Development of a highly cardioselective ultrashort-acting beta-blocker, ONO-1101","volume":"40","author":"Iguchi","year":"1992","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib33","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1111\/j.1476-5381.1996.tb15637.x","article-title":"Impaired activation of adenylyl cyclase in lung of the Besenji-greyhound model of airway hyperresponsiveness: decreased numbers of high affinity beta-adrenoceptors","volume":"118","author":"Emala","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib34","doi-asserted-by":"crossref","first-page":"C1008","DOI":"10.1152\/ajpcell.2000.279.4.C1008","article-title":"Decreased adenylyl cyclase protein and function in airway smooth muscle by chronic carbachol pretreatment","volume":"279","author":"Emala","year":"2000","journal-title":"Am J Physiol"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib35","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/00000542-199505000-00004","article-title":"Wheezing during induction of general anesthesia in patients with and without asthma","volume":"82","author":"Pizov","year":"1995","journal-title":"Anesthesiology"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib36","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1213\/01.ANE.0000140240.83236.AC","article-title":"The effect of volatile anesthetics on respiratory system resistance in patients with chronic obstructive pulmonary disease","volume":"100","author":"Volta","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib37","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/0002-8703(86)90513-2","article-title":"Intravenous esmolol for the treatment of supraventricular tachyarrhythmia: results of a multicenter, baseline-controlled safety and efficacy study in 160 patients","volume":"112","year":"1986","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib38","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/BF03016588","article-title":"In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol","volume":"48","author":"Sasao","year":"2001","journal-title":"Can J Anesth"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib39","first-page":"1531","article-title":"Phase I study ONO-1101, a new ultra short acting beta1-blocking agent in healthy volunteers","volume":"16","author":"Nakashima","year":"2000","journal-title":"RINSHO IYAKU (written in Japanese)"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF02480087","article-title":"Effect of ONO-1101, a novel short-acting beta-blocker, on hemodynamic responses to isoflurane inhalation and tracheal intubation","volume":"12","author":"Hasuo","year":"1998","journal-title":"J Anesth"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib41","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s002280050232","article-title":"Efficacy of an ultra-short-acting beta-adrenoceptor blocker (ONO-1101) in attenuating cardiovascular responses to endotracheal intubation","volume":"51","author":"Kitamura","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib42","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00003643-200406000-00010","article-title":"Comparative assessment of the effects of alfentanil, esmolol or clonidine when used as adjuvants during induction of general anesthesia","volume":"21","author":"Fernandez-Galinski","year":"2004","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib43","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/00000542-199112000-00002","article-title":"Adverse respiratory events infrequently leading to malpractice suits","volume":"75","author":"Cheney","year":"1991","journal-title":"Anesthesiology"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib44","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/00000542-199005000-00010","article-title":"Adverse respiratory events in anesthesia","volume":"72","author":"Caplan","year":"1990","journal-title":"Anesthesiology"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib45","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00000542-199609000-00003","article-title":"Perioperative respiratory complications in patients with asthma","volume":"85","author":"Warner","year":"1996","journal-title":"Anesthesiology"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib46","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/00003246-200204000-00017","article-title":"Intravenous colforsin daropate, a water-soluble forskolin derivative, prevents thiamylal-fentanyl-induced bronchoconstriction in humans","volume":"30","author":"Wajima","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib47","doi-asserted-by":"crossref","first-page":"930","DOI":"10.2460\/ajvr.1995.56.07.930","article-title":"Effects of alpha2-adrenergic receptor agonist and antagonist drugs on cholinergic contraction in bovine tracheal smooth muscle in vitro","volume":"56","author":"Manning","year":"1995","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00000542-200402000-00026","article-title":"Effects of the alpha2-adrenoceptor agonist dexmedetomidine on bronchoconstriction in dogs","volume":"100","author":"Groeben","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1016\/j.hrtlng.2008.01.002_bib49","first-page":"A1585","article-title":"Effects of alpha2-adrenergic agonists clonidine and dexmedetomidine on enhanced airway tone in ovalbumin-sensitized guinea pigs","volume":"101","author":"Yamakage","year":"2004","journal-title":"Anesthesiology"}],"container-title":["Heart &amp; Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956308000149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956308000149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T06:31:57Z","timestamp":1758954717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147956308000149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0147956308000149"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2008.01.002","relation":{},"ISSN":["0147-9563"],"issn-type":[{"value":"0147-9563","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beta-1 selective adrenergic antagonist landiolol and esmolol can be safely used in patients with airway hyperreactivity","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2008.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}